Priscilla T Reyes

Address:

624 Woodcrest Ln, El Paso, TX 79912

VIN:

1D8GT28K57W683183

Make:

DODGE

Model:

NITRO

Year:

2007

US Patent:

7919108, Apr 5, 2011

Filed:

Mar 8, 2007

Appl. No.:

11/715975

Inventors:

Priscilla Reyes - Duncan OK, US
William F. Moore - Bloomington IN, US
Patrick H. Ruane - Haywood CA, US
Darin G. Schaeffer - Bloomington IN, US
Melinda S. Morrell - Vienna VA, US

Assignee:

Cook Incorporated - Bloomington IN
MED Institute Inc. - West Lafayette IN

International Classification:

A61F 2/00
A61F 2/06
A01N 43/02

US Classification:

424423, 514449, 623 13

Abstract:

This disclosure relates to implantable medical devices coated with a taxane therapeutic agent, such as paclitaxel, in one or more solid form(s) having varying dissolution rates. Particularly preferred coatings comprise amorphous and/or solvated solid forms of taxane therapeutic agents that provide durable coatings that release the taxane over a desired period of time, which can be varied in the absence of a polymer by selecting the type and amount of solid forms of the taxane therapeutic agent in the coating. Other preferred embodiments relate to methods of coating medical devices and methods of treatment. The coatings can provide a sustained release of the taxane therapeutic agent within a body vessel without containing a polymer to achieve the desired rate of paclitaxel elution.

US Patent:

8047282, Nov 1, 2011

Filed:

Aug 25, 2009

Appl. No.:

12/547281

Inventors:

Sam Lewis - Duncan OK, US
Priscilla Reyes - Duncan OK, US
Vijay Gupta - Morrisville NC, US
Brian R. Stoner - Chapel Hill NC, US
Anthony Badalamenti - Katy TX, US

Assignee:

Halliburton Energy Services Inc. - Duncan OK

International Classification:

E21B 33/13
E21B 33/138

US Classification:

166249, 1661771, 1661772, 166286, 166292, 166293, 166295

Abstract:

The present disclosure is directed to a system and method for sonically activating cement slurries. In some implementations, a method of treating a subterranean formation includes positioning a settable composition including a capsule in a wellbore. The capsule is used to increase a setting rate in response to at least sonic signals. A sonic signal is transmitted to at least a portion of the settable composition to release an activator from the capsule.

US Patent:

8083849, Dec 27, 2011

Filed:

Aug 25, 2009

Appl. No.:

12/547275

Inventors:

Sam Lewis - Duncan OK, US
Priscilla Reyes - Duncan OK, US
Craig Roddy - Duncan OK, US
Lynn Davis - Holly Springs NC, US
Mark Roberson - Cary NC, US
Anthony Badalamenti - Katy TX, US

Assignee:

Halliburton Energy Services, Inc. - Duncan OK

International Classification:

C04B 7/00
C04B 7/34
C04B 28/00
C04B 32/00
C04B 16/08
C04B 20/00
C04B 38/00
C04B 14/00
C04B 24/00
C04B 24/10
E21B 43/22
E21B 33/13

US Classification:

106638, 106673, 106677, 106606, 166286, 166282, 166293

Abstract:

The present disclosure is directed to a system and method for managing cement in a subterranean zone. In some implementations, a method of cementing in a subterranean formation includes positioning a cement slurry including a plurality of activation devices in a wellbore. The activation devices configured to release an activator that increases a setting rate of the cement slurry. A signal is transmitted to at least a portion of the cement slurry to activate the activation devices. The activation device releases the activator in response to at least the signal.

US Patent:

8147540, Apr 3, 2012

Filed:

Jan 5, 2011

Appl. No.:

12/984733

Inventors:

Priscilla Reyes - Duncan OK, US
William F. Moore - Bloominton IN, US
Patrick H. Ruane - San Mateo CA, US
Darin G. Schaeffer - Bloomington IN, US
Melinda S. Morrell - Vienna VA, US

Assignee:

Cook Medical Technologies LLC - Bloomington IN

International Classification:

A61F 2/82
A61F 2/00
A61K 31/335
A61M 25/10

US Classification:

623 146, 424423, 514449, 604500

Abstract:

This disclosure relates to implantable medical devices coated with a taxane therapeutic agent, such as paclitaxel, in one or more solid form(s) having varying dissolution rates. Particularly preferred coatings comprise amorphous and/or solvated solid forms of taxane therapeutic agents that provide durable coatings that release the taxane over a desired period of time, which can be varied in the absence of a polymer by selecting the type and amount of solid forms of the taxane therapeutic agent in the coating. Other preferred embodiments relate to methods of coating medical devices and methods of treatment. The coatings can provide a sustained release of the taxane therapeutic agent within a body vessel without containing a polymer to achieve the desired rate of paclitaxel elution.

US Patent:

8162055, Apr 24, 2012

Filed:

Aug 25, 2009

Appl. No.:

12/547233

Inventors:

Sam Lewis - Duncan OK, US
Priscilla Reyes - Duncan OK, US
Craig Roddy - Duncan OK, US
Lynn Davis - Holly Springs NC, US
Mark Roberson - Cary NC, US
Anthony Badalamenti - Katy TX, US

Assignee:

Halliburton Energy Services Inc. - Duncan OK

International Classification:

E21B 33/13

US Classification:

166285, 166 651, 166292, 1661774

Abstract:

The present disclosure is directed to a system and method for managing cement in a subterranean zone. In some implementations, a method of cementing in a subterranean formation includes positioning a cement slurry including a plurality of activation devices in a wellbore. The activation devices configured to release an activator that increases a setting rate of the cement slurry. A signal is transmitted to at least a portion of the cement slurry to activate the activation devices. The activation device releases the activator in response to at least the signal.

US Patent:

8623792, Jan 7, 2014

Filed:

May 31, 2012

Appl. No.:

13/485054

Inventors:

Benjamin J. Iverson - Duncan OK, US
Ashok K. Santra - Duncan OK, US
Priscilla T. Reyes - Duncan OK, US

Assignee:

Halliburton Energy Services, Inc. - Houston TX

International Classification:

C09K 8/88

US Classification:

507219, 1663051

Abstract:

A treatment fluid comprising an aqueous liquid and an associative polymer additive. The associative polymer additive increases the plastic viscosity (PV) of an aqueous liquid by more than at least 50% and wherein the associative polymer additive increases the yield point (YP) by no more than about 30% of the corresponding increase in the PV relative to an aqueous liquid without the associative polymer additive. Moreover, the viscosity of the aqueous liquid comprising the associative polymer additive is capable of maintaining a viscosity of greater than about 20 cP for at least 20 minutes at temperatures higher than about 275 F. In some cases the associative polymer additive may be a hydrophobic alkoxylated aminoplast.

US Patent:

8642063, Feb 4, 2014

Filed:

Aug 20, 2009

Appl. No.:

12/544281

Inventors:

Aparna Reddy Sarasam - West Lafayette IN, US
Angela Rose Barnett - Lafayette IN, US
Krista Nicole Gearhart - Lafayette IN, US
Jason Lichti - West Lafayette IN, US
Priscilla Reyes - Duncan OK, US

Assignee:

Cook Medical Technologies LLC - Bloomington IN

International Classification:

A61F 2/00
A61F 2/02
A61K 31/337

US Classification:

424423, 424422, 604500, 623 11, 514449

Abstract:

A coated medical device, such as a stent, that elutes a taxane agent in a controlled manner is provided. In one embodiment, the taxane agent is paclitaxel and at least a portion of the paclitaxel is present in a dihydrate solid form. The medical device may be coated with a layer including a taxane agent and a layer of bioabsorbable elastomer over the layer including the taxane agent. Methods of manufacturing and using the coated medical device are also provided.

US Patent:

20070196423, Aug 23, 2007

Filed:

Nov 15, 2006

Appl. No.:

11/599850

Inventors:

Patrick Ruane - Redwood City CA, US
Priscilla Reyes - West Lafayette IN, US

Assignee:

MED Institute, Inc. - West Lafayette IN

International Classification:

A61L 33/00

US Classification:

424423000, 427002250

Abstract:

A coated medical device, such as a stent, that elutes a therapeutic agent in a controlled manner is provided. The medical device may be coated with a layer of therapeutic agent and a layer of bioabsorbable elastomer over the layer of therapeutic agent. Methods of manufacturing a coated medical device and of coating a medical device are also provided.